LL-37 inhibits osteosarcoma progression by suppressing SQLE-mediated cholesterol synthesis via the PTEN/AKT/mTOR pathway

Journal of Bone Oncology · Published 2026-06-24 · DOI 10.1016/j.jbo.2026.100779

Free full text

Authors (6)

Fatai Lu, Zhijun Liu, Huasheng Jiang, Hong Zheng, Wenhui Su, Baosen Zhou

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lu, F., Liu, Z., Jiang, H., et al. (2026). LL-37 inhibits osteosarcoma progression by suppressing SQLE-mediated cholesterol synthesis via the PTEN/AKT/mTOR pathway. Journal of Bone Oncology. https://doi.org/10.1016/j.jbo.2026.100779

Related articles

• Post-operative survival and use of systemic therapy in metastatic long-bone disease: 12 years of institutional experience · Journal of Bone Oncology · 2026 · Same journal
• Risk of fracture among lung cancer survivors by cancer treatment modality: A population-based retrospective cohort study · Journal of Bone Oncology · 2026 · Same journal
• Assessing the mechanism of osteosarcoma induced by long-term PET exposure: prediction from combined network toxicology, machine learning and molecular docking · Journal of Bone Oncology · 2025 · Same journal
• Opinion statement regarding the use of post-operative radiotherapy after surgery for pathological fractures of the long bones: An answer to the points raised regarding methodology and analysis · Journal of Bone Oncology · 2026 · Same journal
• Clinically aligned whole-body MRI segmentation of skeletal metastases via Supervised Anatomical Pretraining · Journal of Bone Oncology · 2026 · Same journal
• Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype · Journal of Bone Oncology · 2026 · Same journal
• Mri-based habitat and peritumoral radiomics for predicting the proliferative activity of stromal cells in giant cell tumor of bone · Journal of Bone Oncology · 2025 · Same journal
• Risk factors and clinical impact of bone pain in patients with multiple myeloma – A prospective interdisciplinary study · Journal of Bone Oncology · 2026 · Same journal
• Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants · Journal of Bone Oncology · 2025 · Same journal
• Alteration of bone architecture following androgen deprivation therapy in patients with prostate cancer using 3D-modeling from hip DXA · Journal of Bone Oncology · 2025 · Same journal